Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell CancerJoão Lobo, Robert J. Hamilton, Ad Gillis et al.|European Urology Oncology|2020Cited by 69